Current Neuropharmacology
Volume 18, 12 Issues, 2020
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 16 - Number 5
Biography Open Access
Editorial Open Access
Review Article
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
, 16(5): 508 - 518Marc Fakhoury*
DOI: 10.2174/1570159X15666170720095240
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Review Article
Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder
, 16(5): 519 - 532Jairo Vinicius Pinto, Ives Cavalcante Passos, Diego Librenza-Garcia, Grasiela Marcon, Maiko Abel Schneider, Joao Henrique Conte, Joao Pedro Abreu da Silva, Luiza Pereira Lima, Andre Quincozes-Santos, Marcia Kauer-Sant`Anna and Flavio Kapczinski*
DOI: 10.2174/1570159X15666170828170921
Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder
Review Article
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
, 16(5): 533 - 558Jennifer C. Felger*
DOI: 10.2174/1570159X15666171123201142
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Review Article
The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
, 16(5): 559 - 573Yong-Ku Kim and Cheolmin Shin*
DOI: 10.2174/1570159X15666170915141036
The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
Review Article
Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
, 16(5): 574 - 582Yong-Ku Kim and Sang Won Jeon*
DOI: 10.2174/1570159X15666170913110426
Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
Review Article
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
, 16(5): 583 - 606Laura Orsolini, Fabiola Sarchione, Federica Vellante, Michele Fornaro, Ilaria Matarazzo , Giovanni Martinotti, Alessandro Valchera, Marco Di Nicola, Alessandro Carano, Massimo Di Giannantonio, Giampaolo Perna, Luigi Olivieri and Domenico De Berardis*
DOI: 10.2174/1570159X16666180119144538
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Editorial Open Access
Editorial; The Role of Ca2+-activated K+ Channels of Intermediate Conductance in Glioblastoma Malignancy
, 16(5): 607Luigi Catacuzzeno and Fabio Franciolini
DOI: 10.2174/1570159X1605180510154222
Review Article
Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance
, 16(5): 608 - 617Luigi Sforna, Alfredo Megaro, Mauro Pessia, Fabio Franciolini* and Luigi Catacuzzeno*
DOI: 10.2174/1570159X15666170830122402
Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance
Review Article
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
, 16(5): 618 - 626Brandon M. Brown, Brandon Pressley and Heike Wulff*
DOI: 10.2174/1570159X15666170630164226
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
Review Article
KCa3.1 Channels and Glioblastoma: In Vitro Studies
, 16(5): 627 - 635Lukas Klumpp, Efe C. Sezgin, Marco Skardelly, Franziska Eckert and Stephan M. Huber*
DOI: 10.2174/1570159X15666170808115821
KCa3.1 Channels and Glioblastoma: In Vitro Studies
Review Article
Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors
, 16(5): 636 - 643Giuseppina D`Alessandro, Cristina Limatola* and Myriam Catalano
DOI: 10.2174/0929867324666170713103621
Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net